International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 12

Review Papers | Biotechnology | Volume 10 Issue 7, July 2021 | Pages: 888 - 890 | India


In Silico Studies on Identification of Novel Therapeutic Targets for Treatment of Diabetes: A Review

Shivani Singh

Abstract: The expressed sequence tags (ESTs) are major entities for gene discovery, molecular transcripts, and single nucleotide polymorphism (SNPs) analysis as well as functional annotation of putative gene products. In our quest for identification of novel diabetic genes as virtual targets for type II diabetes, databases and Methods used in silico evaluation are illustrated. The functional and structural annotations of these proteins revealed some important features which may lead to the discovery of novel therapeutic targets for the treatment of diabetes.

Keywords: Expressed sequence tags, Single nucleotide polymorphism, molecular transcripts

How to Cite?: Shivani Singh, "In Silico Studies on Identification of Novel Therapeutic Targets for Treatment of Diabetes: A Review", Volume 10 Issue 7, July 2021, International Journal of Science and Research (IJSR), Pages: 888-890, https://www.ijsr.net/getabstract.php?paperid=SR21704110405, DOI: https://dx.doi.org/10.21275/SR21704110405

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.